Cargando…

Chemical Modifications of mRNA Ends for Therapeutic Applications

[Image: see text] Messenger ribonucleic acid (mRNA) is the universal cellular instruction for ribosomes to produce proteins. Proteins are responsible for most of the functions of living organisms, and their abnormal structure or activity is the cause of many diseases. mRNA, which is expressed in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warminski, Marcin, Mamot, Adam, Depaix, Anaïs, Kowalska, Joanna, Jemielity, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586375/ https://www.ncbi.nlm.nih.gov/pubmed/37782471 http://dx.doi.org/10.1021/acs.accounts.3c00442

Ejemplares similares

Applications of Phosphate Modification and Labeling to Study (m)RNA Caps
por: Warminski, Marcin, et al.
Publicado: (2017)

Biomolecular condensates amplify mRNA decapping by biasing enzyme conformation
por: Tibble, Ryan W., et al.
Publicado: (2021)

2′-O-Methylation of the second transcribed nucleotide within the mRNA 5′ cap impacts the protein production level in a cell-specific manner and contributes to RNA immune evasion
por: Drazkowska, Karolina, et al.
Publicado: (2022)

Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression
por: Strzelecka, Dominika, et al.
Publicado: (2020)

Towards superior mRNA caps accessible by click chemistry: synthesis and translational properties of triazole-bearing oligonucleotide cap analogs
por: Kozarski, Mateusz, et al.
Publicado: (2023)

Preparation of RNAs with non-canonical 5′ ends using novel di- and trinucleotide reagents for co-transcriptional capping
por: Depaix, Anaïs, et al.
Publicado: (2022)

Quick Access to Nucleobase-Modified Phosphoramidites for the Synthesis of Oligoribonucleotides Containing Post-Transcriptional Modifications and Epitranscriptomic Marks
por: Ziemkiewicz, Kamil, et al.
Publicado: (2022)

The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells
por: Sikorski, Pawel J, et al.
Publicado: (2020)

NAD Analogs in Aid of Chemical Biology and Medicinal Chemistry
por: Depaix, Anais, et al.
Publicado: (2019)

Kinetic analysis of IFIT1 and IFIT5 interactions with different native and engineered RNAs and its consequences for designing mRNA-based therapeutics
por: Miedziak, Beata, et al.
Publicado: (2020)

Ethylenediamine derivatives efficiently react with oxidized RNA 3′ ends providing access to mono and dually labelled RNA probes for enzymatic assays and in vivo translation
por: Mamot, Adam, et al.
Publicado: (2021)

5′-fluoro(di)phosphate-labeled oligonucleotides are versatile molecular probes for studying nucleic acid secondary structure and interactions by (19)F NMR
por: Baranowski, Marek R, et al.
Publicado: (2020)

mRNA cap analogues substituted in the tetraphosphate chain with CX(2): identification of O-to-CCl(2) as the first bridging modification that confers resistance to decapping without impairing translation
por: Rydzik, Anna M., et al.
Publicado: (2017)

Structural Insights into the Interaction of Clinically Relevant Phosphorothioate mRNA Cap Analogs with Translation Initiation Factor 4E Reveal Stabilization via Electrostatic Thio-Effect
por: Warminski, Marcin, et al.
Publicado: (2021)

Fluorescence-Based Activity Screening Assay Reveals Small Molecule Inhibitors of Vaccinia Virus mRNA Decapping Enzyme D9
por: Bednarczyk, Marcelina, et al.
Publicado: (2022)

N1-Propargylguanosine Modified mRNA Cap Analogs: Synthesis, Reactivity, and Applications to the Study of Cap-Binding Proteins
por: Kopcial, Michal, et al.
Publicado: (2019)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
por: Liu, Albert, et al.
Publicado: (2022)

Evaluation of carboxyfluorescein-labeled 7-methylguanine nucleotides as probes for studying cap-binding proteins by fluorescence anisotropy
por: Wojtczak, Anna, et al.
Publicado: (2021)

Structural basis of mRNA cap recognition by Dcp1–Dcp2
por: Mugridge, Jeffrey S, et al.
Publicado: (2016)

Enzymatic Assays to Explore Viral mRNA Capping Machinery
por: Kasprzyk, Renata, et al.
Publicado: (2021)

Chemically Modified Poly(A) Analogs Targeting PABP: Structure Activity Relationship and Translation Inhibitory Properties
por: Perzanowska, Olga, et al.
Publicado: (2022)

Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes
por: Kowalska, Joanna, et al.
Publicado: (2014)

Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential
por: Strenkowska, Malwina, et al.
Publicado: (2016)

Novel N7-Arylmethyl Substituted Dinucleotide mRNA 5′ cap Analogs: Synthesis and Evaluation as Modulators of Translation †
por: Wojcik, Radoslaw, et al.
Publicado: (2021)

Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase
por: Kasprzyk, Renata, et al.
Publicado: (2021)

mRNA knockdown by single strand RNA is improved by chemical modifications
por: Haringsma, Henry J., et al.
Publicado: (2012)

Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope
por: Jiang, Tingting, et al.
Publicado: (2020)

Structure of the activated Edc1-Dcp1-Dcp2-Edc3 mRNA decapping complex with substrate analog poised for catalysis
por: Mugridge, Jeffrey S., et al.
Publicado: (2018)

In search of the mRNA modification landscape in plants
por: Chmielowska-Bąk, Jagna, et al.
Publicado: (2019)

Two-headed tetraphosphate cap analogs are inhibitors of the Dcp1/2 RNA decapping complex
por: Ziemniak, Marcin, et al.
Publicado: (2016)

Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity
por: Uchida, Satoshi, et al.
Publicado: (2015)

New mRNA modification?
por: Leslie, Mitch
Publicado: (2007)

Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery
por: Han, Geonhee, et al.
Publicado: (2023)

Introducing SuFNucs: Sulfamoyl-Fluoride-Functionalized Nucleosides That Undergo Sulfur Fluoride Exchange Reaction
por: Chrominski, Mikołaj, et al.
Publicado: (2022)

Application of mRNA Technology in Cancer Therapeutics
por: Eralp, Yesim
Publicado: (2022)

Chemical Modification of Cellulose Microfibres to Reinforce Poly(methyl methacrylate) Used for Dental Application
por: Taczała, Joanna, et al.
Publicado: (2020)

RNA modification in mRNA cancer vaccines
por: Mei, Yingxue, et al.
Publicado: (2023)

Analysis of mononucleotides by tandem mass spectrometry: investigation of fragmentation pathways for phosphate- and ribose-modified nucleotide analogues
por: Strzelecka, Dominika, et al.
Publicado: (2017)

Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases
por: Elkhalifa, Dana, et al.
Publicado: (2022)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0kkg6mi861a8r1n60bs4m0iodb